DIACEUTICS PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 132.5 GBX | 0.00% |
|
+3.52% | +52.30% |
| 28/05 | Sirius Real Estate Non-Exec Director James Peggie to resign | AN |
| 24/05 | Michael Ashcroft ups stake in Marlowe to 16% | AN |
Presenter SpeechUnknown Executive (Executives)Good afternoon, everybody. I appreciate they say...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Diaceutics PLC is a United Kingdom-based company, which is a provider of technology and solutions. The Company provides pharma and biotech companies with an end-to-end commercialization solution for precision medicine through data analytics, scientific and advisory services enabled by its platform DXRX - The Diagnostics Network. The Company operates through three segments: Insight Solutions (Data), Engagement Solutions (Tech enabled services), and Advisory Services (Professional services). The Companyâs DXRX - The Diagnostics Network is a diagnostic commercialization platform for precision medicine, integrating multiple pipelines of real-world diagnostic testing data from a global network of laboratories. It provides unrivalled access to multiple pipelines of real-world diagnostic testing data from a global network of laboratories. Its Tech Enabled Services offers clinical testing labs to provide enablement and educational services in novel biomarkers.
Sector
Business Support Services
Calendar
12/06/2024
- Capital Markets Day
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
1.325
GBP
Average target price
1.678
GBP
Spread / Average Target
+26.64%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +52.30% | 14Cr | |
| +15.11% | 443.62Cr | |
| -20.55% | 229.44Cr | |
| +34.11% | 205.08Cr | |
| -10.91% | 154.94Cr | |
| -0.45% | 153.5Cr | |
| -24.16% | 146.33Cr | |
| -32.92% | 113.84Cr | |
| -12.87% | 111.59Cr | |
| -11.78% | 101.97Cr |
- Stock Market
- Equities
- DXRX Stock
- News Diaceutics PLC
- Transcript : Diaceutics PLC, 2023 Earnings Call, May 21, 2024
